5 predictions for private equity in healthcare
Grant Thornton principal Lisa Walkush explains why healthcare remains one of the most attractive options for private equity firms.
Grant Thornton principal Lisa Walkush explains why healthcare remains one of the most attractive options for private equity firms.
The investment aims to reduce “bottlenecks in nurse training” that stakeholders say hamper recruitment efforts.
CEO Jeff Tangney attributed the company’s slowdown to “post-COVID upsell weakness,” while also reducing Doximity’s revenue guidance for fiscal year 2024.
Continuing financial pressures could keep deal-making low in the second half of the year, but M&A could heat up in early 2024, a new KPMG report finds.
Star ratings bonuses jumped 30% from 2022 to 2023 to reach $12.8 billion, according to the KFF, as the Medicare program faces a growing spending crisis.
The nation’s largest for-profit operators posted revenue results that beat Wall Street expectations on rebounding patient demand, and reported progress on labor initiatives.
The study, published in Health Affairs, found large national insurers had higher price ratios than other payers.
Hospital CEO turnover remained depressed last year, according to one report, but separate research suggests executive changes were on the rise as of June.
Clover notched its first quarterly adjusted EBITDA profit as a public company, while Oscar reached total company profitability for the second quarter in a row. Meanwhile, Bright posted its first quarter ever with positive adjusted EBITDA.
The letter, sent by a bipartisan group of senators to tax commissioners, comes as the federal government increases scrutiny into nonprofit hospitals’ charity care spending.